2nd Quarter - Report — GREENWICH BIOSCIENCES, INC. for GREENWICH BIOSCIENCES, INC. (2019)

Firm

GREENWICH BIOSCIENCES, INC.

Client

GREENWICH BIOSCIENCES, INC.

Income

—

Expenses

$260,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

The STATES Act (S. 3032/H.R. 6043) - Issues related to the FDA; Regulation of cannabis based medicines; Regulations to implement 2018 Farm Bill Provisions

Lobbyist	Covered position, as disclosed
ALICE P. MEAD	—
DEBORAH LYNN WALTER	—

Contacted: Drug Enforcement Administration (DEA); Agriculture, Dept of (USDA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA)

Bills named: S. 3032 (116th), H.R. 6043 (116th)

Budget/Appropriations BUD

2019 Consolidated Appropriations Act (H.R. 648) - Sections 536 & 537's impact on other agencies

Lobbyist	Covered position, as disclosed
ALICE P. MEAD	—
DEBORAH LYNN WALTER	—

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA); Drug Enforcement Administration (DEA); Agriculture, Dept of (USDA)

Bills named: H.R. 648 (116th)

Consumer Issues/Safety/Products CSP

FDA regulation of cannabidiol in medicines and consumer products

Lobbyist	Covered position, as disclosed
ALICE P. MEAD	—
DEBORAH LYNN WALTER	—

Contacted: Food & Drug Administration (FDA); SENATE; Drug Enforcement Administration (DEA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Agriculture, Dept of (USDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.